Price T Rowe Associates Inc Biolife Solutions Inc Transaction History
Price T Rowe Associates Inc
- $869 Billion
- Q3 2024
A detailed history of Price T Rowe Associates Inc transactions in Biolife Solutions Inc stock. As of the latest transaction made, Price T Rowe Associates Inc holds 16,811 shares of BLFS stock, worth $460,453. This represents 0.0% of its overall portfolio holdings.
Number of Shares
16,811
Previous 16,407
2.46%
Holding current value
$460,453
Previous $352,000
19.6%
% of portfolio
0.0%
Previous 0.0%
Shares
12 transactions
Others Institutions Holding BLFS
# of Institutions
198Shares Held
44.9MCall Options Held
8.2KPut Options Held
4K-
Casdin Capital, LLC New York, NY8.71MShares$238 Million16.93% of portfolio
-
Black Rock Inc. New York, NY5.49MShares$150 Million0.0% of portfolio
-
Invesco Ltd. Atlanta, GA3.2MShares$87.7 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.85MShares$78 Million0.0% of portfolio
-
Fred Alger Management, LLC New York, NY1.58MShares$43.2 Million0.2% of portfolio
About BIOLIFE SOLUTIONS INC
- Ticker BLFS
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 42,684,400
- Market Cap $1.17B
- Description
- BioLife Solutions, Inc. develops, manufactures, and supplies bioproduction tools and services for the cell and gene therapy industry in the United States, Canada, Europe, the Middle East, Africa, and internationally. The company's products are used in the basic and applied research, and commercial manufacturing of biologic-based therapies. It of...